Doudna Lab News Today

Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types

Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types Mammoth...

Benjamin Oakes Scribe Therapeutics is developing specialized Crispr proteins for multiple diseases–and it’s got deals with Big Pharma potentially worth over $4 billion

On Monday, scientists at UC Berkeley's Doudna Lab published research on a new system for targeting RNA sequences using clustered regularly interspaced short palindromic repeats, or CRISPR, an adaptive immune system present in bacteria, paving the way for additional research and potential medical use.

Researchers at UC Berkeley and UCSF’s  Innovative Genomics Institute, or IGI, have found the diversity of CRISPR gene editors in viruses goes far beyond what they expected, possibly leading to new ways of editing genomes. 

Mar 10, 2021 at 6:30AM You may know Walter Isaacson from his biographies of Steve Jobs, Benjamin Franklin, Leonardo Da Vinci, or Albert Einstein. In his latest book, the author, journalist, and professor tells the story of a new subject who has had a huge impact on the scientific community, the gene-editing field, and even the coronavirus pandemic: Dr. Jennifer Doudna.  In this March 9, Fool.com Bureau Chief Corinne Cardina interviews Isaacson about his new book title...